Literature DB >> 28522440

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.

Martin Bjerregård Pedersen1, Stephen Jacques Hamilton-Dutoit2, Knud Bendix2, Rhett P Ketterling3, Patrick P Bedroske3, Ivy M Luoma3, Christopher A Sattler3, Rebecca L Boddicker3, N Nora Bennani4, Peter Nørgaard5, Michael Boe Møller6, Torben Steiniche2, Francesco d'Amore1, Andrew L Feldman3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28522440      PMCID： PMC5533203          DOI： 10.1182/blood-2016-12-755496

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 2.  Chromosomal translocations: revisited yet again.

Authors:  Janet D Rowley
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

3.  A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.

Authors:  Thirunavukkarasu Velusamy; Mark J Kiel; Anagh A Sahasrabuddhe; Delphine Rolland; Catherine A Dixon; Nathanael G Bailey; Bryan L Betz; Noah A Brown; Alexandra C Hristov; Ryan A Wilcox; Roberto N Miranda; L Jeffrey Medeiros; Yoon K Jeon; Kedar V Inamdar; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

4.  Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

Authors:  Irene Scarfò; Elisa Pellegrino; Elisabetta Mereu; Ivo Kwee; Luca Agnelli; Elisa Bergaggio; Giulia Garaffo; Nicoletta Vitale; Manuel Caputo; Rodolfo Machiorlatti; Paola Circosta; Francesco Abate; Antonella Barreca; Domenico Novero; Susan Mathew; Andrea Rinaldi; Enrico Tiacci; Sara Serra; Silvia Deaglio; Antonino Neri; Brunangelo Falini; Raul Rabadan; Francesco Bertoni; Giorgio Inghirami; Roberto Piva
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Authors:  R D Gascoyne; P Aoun; D Wu; M Chhanabhai; B F Skinnider; T C Greiner; S W Morris; J M Connors; J M Vose; D S Viswanatha; A Coldman; D D Weisenburger
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

7.  Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.

Authors:  Vivien Mak; Jeremey Hamm; Mukesh Chhanabhai; Tamara Shenkier; Richard Klasa; Laurie H Sehn; Diego Villa; Randy D Gascoyne; Joseph M Connors; Kerry J Savage
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

8.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

9.  High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.

Authors:  Martin B Pedersen; Allan V Danielsen; Stephen J Hamilton-Dutoit; Knud Bendix; Peter Nørgaard; Michael B Møller; Torben Steiniche; Francesco d'Amore
Journal:  Histopathology       Date:  2014-04-16       Impact factor: 5.087

10.  Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

Authors:  Francesco d'Amore; Thomas Relander; Grete F Lauritzsen; Esa Jantunen; Hans Hagberg; Harald Anderson; Harald Holte; Anders Österborg; Mats Merup; Peter Brown; Outi Kuittinen; Martin Erlanson; Bjørn Østenstad; Unn-Merete Fagerli; Ole V Gadeberg; Christer Sundström; Jan Delabie; Elisabeth Ralfkiaer; Martine Vornanen; Helle E Toldbod
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544
View more
  25 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.

Authors:  Jess F Peterson; Kathryn E Pearce; Reid G Meyer; Patricia T Greipp; Ryan A Knudson; Linda B Baughn; Rhett P Ketterling; Andrew L Feldman
Journal:  Histopathology       Date:  2020-01-17       Impact factor: 5.087

3.  DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.

Authors:  Arantza Onaindia; Sonia González de Villambrosía; Lucía Prieto-Torres; Socorro M Rodríguez-Pinilla; Santiago Montes-Moreno; Carmen González-Vela; Miguel A Piris
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941

4.  Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Authors:  Naoki Oishi; Garry S Brody; Rhett P Ketterling; David S Viswanatha; Rong He; Surendra Dasari; Ming Mai; Hailey K Benson; Christopher A Sattler; Rebecca L Boddicker; Ellen D McPhail; N Nora Bennani; Christin A Harless; Kuldeep Singh; Mark W Clemens; L Jeffrey Medeiros; Roberto N Miranda; Andrew L Feldman
Journal:  Blood       Date:  2018-06-19       Impact factor: 22.113

5.  Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

Authors:  Rebecca A Luchtel; Surendra Dasari; Naoki Oishi; Martin Bjerregård Pedersen; Guangzhen Hu; Karen L Rech; Rhett P Ketterling; Jagmohan Sidhu; Xueju Wang; Ryohei Katoh; Ahmet Dogan; N Sertac Kip; Julie M Cunningham; Zhifu Sun; Saurabh Baheti; Julie C Porcher; Jonathan W Said; Liuyan Jiang; Stephen Jacques Hamilton-Dutoit; Michael Boe Møller; Peter Nørgaard; N Nora Bennani; Wee-Joo Chng; Gaofeng Huang; Brian K Link; Fabio Facchetti; James R Cerhan; Francesco d'Amore; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2018-08-09       Impact factor: 22.113

6.  Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.

Authors:  Rebecca A Luchtel; Michael T Zimmermann; Guangzhen Hu; Surendra Dasari; Manli Jiang; Naoki Oishi; Hailey K Jacobs; Yu Zeng; Tanya Hundal; Karen L Rech; Rhett P Ketterling; Jeong-Heon Lee; Bruce W Eckloff; Huihuang Yan; Krutika S Gaonkar; Shulan Tian; Zhenqing Ye; Marshall E Kadin; Jagmohan Sidhu; Liuyan Jiang; Jesse Voss; Brian K Link; Sergei I Syrbu; Fabio Facchetti; N Nora Bennani; Susan L Slager; Tamas Ordog; Jean-Pierre Kocher; James R Cerhan; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

7.  Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.

Authors:  Johanne M Holst; Trine L Plesner; Martin B Pedersen; Henrik Frederiksen; Michael B Møller; Michael R Clausen; Marcus C Hansen; Stephen Jacques Hamilton-Dutoit; Peter Nørgaard; Preben Johansen; Tobias Ramm Eberlein; Bo K Mortensen; Gustav Mathiasen; Andreas Øvlisen; Rui Wang; Chao Wang; Weiwei Zhang; Hans Beier Ommen; Jesper Stentoft; Maja Ludvigsen; Wayne Tam; Wing C Chan; Giorgio Inghirami; Francesco d'Amore
Journal:  Haematologica       Date:  2019-11-28       Impact factor: 9.941

8.  Peripheral T-cell lymphoma diagnosis: building a molecular tool.

Authors:  Miguel A Piris
Journal:  Haematologica       Date:  2020-06       Impact factor: 9.941

9.  Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.

Authors:  Maja Ludvigsen; Martin Bjerregård Pedersen; Kristina Lystlund Lauridsen; Tim Svenstrup Poulsen; Stephen Jacques Hamilton-Dutoit; Søren Besenbacher; Knud Bendix; Michael Boe Møller; Peter Nørgaard; Francesco d'Amore; Bent Honoré
Journal:  Blood Adv       Date:  2018-10-09

Review 10.  How to Sequence Therapies in Peripheral T Cell Lymphoma.

Authors:  Kitsada Wudhikarn; N Nora Bennani
Journal:  Curr Treat Options Oncol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.